3D imaging reveals nerve structure in rat knee joints, informing temporomandibular disorder research

Temporomandibular disorders (TMDs) encompass more than 30 distinct conditions that produce pain, clicking, and limited movement of the jaw joint. A recent study has highlighted an unexpected source of therapeutic material: a small tissue sample taken from the knee joint of laboratory rats. Researchers have isolated mesenchymal stem cells (MSCs) from the meniscal cartilage of these animals, cultured them, and demonstrated that the cells can differentiate into chondrocyte‑like cells capable of producing extracellular matrix similar to that found in the temporomandibular joint (TMJ).

In preclinical trials, the cultured MSCs were injected into the TMJ of rodent models with induced TMD pathology. The treated animals showed a significant reduction in joint inflammation, improved range of motion, and histological evidence of cartilage repair compared with untreated controls. The choice of knee-derived MSCs is driven by their accessibility, robust proliferative capacity, and proven safety profile in other cartilage repair applications, making them a practical candidate for translational research into human TMD therapy.

If these findings translate to clinical settings, a minimally invasive procedure could become available for patients suffering from chronic jaw pain. Ongoing studies aim to optimize cell delivery methods, dosage, and long‑term outcomes, with the goal of establishing a new regenerative treatment pathway for TMDs that leverages the regenerative potential of knee‑derived stem cells.